Leila Alland, Chief Medical Officer at PMV Pharmaceuticals, Inc. (PMVP), sold 7,972 shares at $33.86 ($270K) on 2021-04-07, disclosed to the SEC on 2021-04-08.
Open-market sale of $270k PMVP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.86 | 3,972 | $134K | 49.8% |
| 2 | $33.86 | 3,972 | $134K | 49.8% |
| 3 | $34.42 | 28 | $964 | 0.4% |
| Total | $33.86 avg | 7,972 | $270K | 100% |
| Filing → |
| ABEO | BUY | 2024-05-20 | $52K | — | Filing → |
| ABEO | SELL | 2023-09-29 | $28K | — | Filing → |
| PMVP | SELL | 2023-09-18 | $42K | — | Filing → |